To Get Help Now
Click Here
Today's Date:

Thalidomide birth defects victims file lawsuit in Philadelphia

AddThis Social Bookmark Button

A group of 13 Americans have filed a lawsuit against pharmaceutical company Grunenthal, alleging the company conspired to hide the effects of the drug Thalidomide which resulted in severe birth defects.

According to a Bloomberg report, seven men and six women have joined a lawsuit against Grunenthal, now part of GlaxoSmithKline and Sanofi Aventis. Each of the plaintiffs claims they suffered malformations from birth and for years have not known the true cause. The common denominator among the group is the drug Thalidomide, prescribed in the 1950s and ’60s to treat morning sickness among pregnant women.

Each claims their mother was prescribed Thalidomide between the years of 1957 and 1962 and since that time, Grunenthal and the companies which have consumed it have worked to hide side effects reports on the drug.
Thalidomide was approved on a trial basis in the U.S. more than 50 years ago. At that time, reports of side effects like missing or deformed limbs on babies born to mothers who took the drug were only known in Europe and because Grunenthal argued that the drug would only be available on a limited basis in the U.S., those side effects reports were dismissed by domestic regulators.

The lawsuit was filed in a Pennsylvania state court in Philadelphia on Oct. 25, according to the Bloomberg report.
Some other birth defects suffered by those whose mothers were prescribed Thalidomide include missing fingers and toes or the loss of hearing in just one ear.

Lawyers representing the 13 plaintiffs believe that new-found evidence of a cover-up on the part of Grunenthal and other companies could help hundreds of people in the U.S. born with birth defects who haven’t been able to determine a cause. disclaimer: This article: Thalidomide birth defects victims file lawsuit in Philadelphia was posted on Friday, October 28th, 2011 at 6:59 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.